Search
-
-
-
-
-
Health Insurer Financial Performance in 2024
Issue BriefThis analysis of trends in health insurers’ financial data shows that insurers’ gross margins per enrollee dipped slightly in 2024 across four markets, remaining highest in the Medicare Advantage market, followed by the individual (non-group) market, the fully insured group (employer) market, and Medicaid managed care. The analysis also examines insurers’ medical-loss ratios across the four markets.
-
Early Prenatal Care Use Falls, Gaps Widen for Women of Color, CDC Data Show
Quick TakeWhile the exact reasons for the recent declines in early prenatal care use are not known, disparities in maternal and infant health reflect underlying inequities in insurance coverage, access to care, and social and economic factors.
-
What Newly Released Medicaid Data Do and Don’t Tell Us
Policy WatchOn February 14, 2026, CMS released a dataset with provider-level spending data that the agency suggests could be used to identify unusual billing patterns for specific services, states, or providers. This policy watch describes what the data include, what they exclude, and how they could potentially lead to mistaken conclusions given the limitations of the data.
-
Shifting U.S. Vaccine Policy: Explaining Federal Actions and Exploring Public Opinion
Event Date:EventKFF experts shared insights on what the shifting policy for childhood and adult vaccination schedules means for state governments, the U.S. public health system, and Americans.
-
-
Intrauterine Devices (IUDs): Access and Coverage in the U.S.
Fact SheetIntrauterine devices (IUDs), along with implants, are known as long-acting reversible contraception (LARCs) because they can be used to prevent pregnancy for several years. This fact sheet reviews FDA-approved IUDs, as well as use, availability, and key issues in insurance coverage and financing of IUDs in the U.S.